Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach - Summary - MDSpire

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

  • By

  • Masumi Ueda Oshima

  • Brenda M. Sandmaier

  • Effie Petersdorf

  • Mary E. Flowers

  • Geoffrey R. Hill

  • Stephanie J. Lee

  • Frederick R. Appelbaum

  • Paul A. Carpenter

  • K. Scott Baker

  • Laura Connelly-Smith

  • Andrea McCool

  • Suni Elgar

  • Steven A. Pergam

  • Catherine Liu

  • F. Marc Stewart

  • Marco Mielcarek

  • September 26, 2020

  • 0 min

Share

Objective:

Emphasize the pandemic's impact on transplant care.

Key Findings:
  • Include specific outcomes or metrics.
Interpretation:

Elaborate on the influence of adaptability on patient outcomes.

Limitations:
  • Mention potential biases in data collection.
Conclusion:

Reiterate implications for future public health crises.

Original Source(s)

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

  • by Masumi Ueda Oshima, Brenda M. Sandmaier, Effie Petersdorf, Mary E. Flowers, Geoffrey R. Hill, Stephanie J. Lee, Frederick R. Appelbaum, Paul A. Carpenter, K. Scott Baker, Laura Connelly-Smith, Andrea McCool, Suni Elgar, Steven A. Pergam, Catherine Liu, F. Marc Stewart, Marco Mielcarek

  • September 26, 2020

Related Content

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

Rare COVID Vaccine Clotting Linked to Adenoviral Protein 

Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies 

  • April 21, 2026

  • 2 min
Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression